Gregory Lucier will continue to serve, now in a permanent capacity, as the CEO of medical devicemaker NuVasive.
Lucier, 51, has served as chairman and interim CEO since March and has been on the company’s board since December 2013.
His appointment comes after the San Diego-based manufacturer of spine devices went through a dramatic leadership transition this year. The company announced Alex Lukianov, April 1 that NuVasive’s founder and CEO since 1999, had resigned after an independent audit found he did not comply with the company’s “expense reimbursement and personnel policies.” The company did not disclose how much money was involved but said the amount was immaterial.
Before joining NuVasive, Lucier was chairman and CEO of biotechnology firm Life Technologies, where he worked for 11 years. He also served as a corporate officer at General Electric Co. and an executive at GE Medical Systems.